Jagsonpal Pharmaceuticals Limited (BOM:507789)
186.20
+1.35 (0.73%)
At close: Apr 2, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 12.47 billion as of April 2, 2026. Its market cap has decreased by -11.75% in one year.
Market Cap
12.47B
Enterprise Value
10.97B
Revenue
2.82B
Ranking
n/a
PE Ratio
30.49
Stock Price
186.20
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 12.47B, a decrease of -29.27%. That is a compound annual growth rate of -1.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 12.43B | -3.35% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 68.19B |
| Suven Life Sciences | 35.04B |
| Gujarat Themis Biosyn | 24.78B |
| IOL Chemicals and Pharmaceuticals | 21.35B |
| NGL Fine-Chem | 12.80B |
| Bajaj HealthCare | 9.15B |
| Anlon Healthcare | 5.92B |
| Shree Ganesh Remedies | 5.39B |